{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T14:31:22Z","timestamp":1776954682997,"version":"3.51.4"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:00:00Z","timestamp":1736035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:00:00Z","timestamp":1736035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Iran Uiversity of Medical Sciences","award":["1400-3-4-22138"],"award-info":[{"award-number":["1400-3-4-22138"]}]},{"name":"Iran Uiversity of Medical Sciences","award":["1400-3-4-22138"],"award-info":[{"award-number":["1400-3-4-22138"]}]},{"name":"Iran Uiversity of Medical Sciences","award":["1400-3-4-22138"],"award-info":[{"award-number":["1400-3-4-22138"]}]},{"name":"Iran Uiversity of Medical Sciences","award":["1400-3-4-22138"],"award-info":[{"award-number":["1400-3-4-22138"]}]},{"name":"Iran Uiversity of Medical Sciences","award":["1400-3-4-22138"],"award-info":[{"award-number":["1400-3-4-22138"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-024-03584-y","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T17:15:10Z","timestamp":1736097310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A1, an innovative fluorinated CXCR4 inhibitor, redefines the therapeutic landscape in colorectal cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Hossein","family":"Khorramdelazad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kowsar","family":"Bagherzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Darehkordi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milad","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Khoshmirsafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamhossein","family":"Hassanshahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaheh","family":"Safari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Falak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,5]]},"reference":[{"issue":"7","key":"3584_CR1","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3390\/cancers14071732","volume":"14","author":"MS Hossain","year":"2022","unstructured":"Hossain MS, et al. Colorectal cancer: a review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers. 2022;14(7):1732.","journal-title":"Cancers"},{"issue":"1","key":"3584_CR2","doi-asserted-by":"publisher","first-page":"14769","DOI":"10.1038\/s41598-019-51361-z","volume":"9","author":"D Chandel","year":"2019","unstructured":"Chandel D, et al. Isolation, characterization and identification of antigenotoxic and anticancerous indigenous probiotics and their prophylactic potential in experimental colon carcinogenesis. Sci Rep. 2019;9(1):14769.","journal-title":"Sci Rep"},{"key":"3584_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s12029-020-00399-8","volume":"52","author":"FL Martin","year":"2021","unstructured":"Martin FL, et al. Age-related and gender-related increases in colorectal cancer mortality rates in Brazil between 1979 and 2015: projections for continuing rises in disease. J Gastrointest Cancer. 2021;52:280\u20138.","journal-title":"J Gastrointest Cancer"},{"issue":"3","key":"3584_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, et al. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233\u201354.","journal-title":"CA Cancer J Clin"},{"issue":"14","key":"3584_CR5","doi-asserted-by":"publisher","first-page":"7371","DOI":"10.3390\/ijms22147371","volume":"22","author":"T Khare","year":"2021","unstructured":"Khare T, Bissonnette M, Khare S. CXCL12-CXCR4\/CXCR7 axis in colorectal cancer: Therapeutic target in preclinical and clinical studies. Int J Mol Sci. 2021;22(14):7371.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"3584_CR6","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.3390\/cancers14071810","volume":"14","author":"AA Go\u00efta","year":"2022","unstructured":"Go\u00efta AA, Guenot D. Colorectal cancer: the contribution of CXCL12 and its receptors CXCR4 and CXCR7. Cancers. 2022;14(7):1810.","journal-title":"Cancers"},{"key":"3584_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jneuroim.2015.11.021","volume":"290","author":"H Khorramdelazad","year":"2016","unstructured":"Khorramdelazad H, et al. New insights into the role of stromal cell-derived factor 1 (SDF-1\/CXCL12) in the pathophysiology of multiple sclerosis. J Neuroimmunol. 2016;290:70\u20135.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"3584_CR8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1600-0897.2012.01167.x","volume":"68","author":"F Aminzadeh","year":"2012","unstructured":"Aminzadeh F, et al. Differential expression of CXC Chemokines CXCL 10 and CXCL 12 in Term and Pre-term Neonates and Their Mothers. Am J Reprod Immunol. 2012;68(4):338\u201344.","journal-title":"Am J Reprod Immunol"},{"issue":"4","key":"3584_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000494435","volume":"25","author":"V Bagheri","year":"2019","unstructured":"Bagheri V, et al. CXCL12 and CXCR4 in the peripheral blood of patients with Parkinson\u2019s disease. NeuroImmunoModulation. 2019;25(4):201\u20135.","journal-title":"NeuroImmunoModulation"},{"key":"3584_CR10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s12031-011-9672-6","volume":"47","author":"H Azin","year":"2012","unstructured":"Azin H, et al. The SDF-1 3\u2032 a genetic variation of the chemokine SDF-1\u03b1 (CXCL12) in parallel with its increased circulating levels is associated with susceptibility to MS: a study on Iranian multiple sclerosis patients. J Mol Neurosci. 2012;47:431\u20136.","journal-title":"J Mol Neurosci"},{"issue":"5","key":"3584_CR11","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.arcmed.2010.07.001","volume":"41","author":"G Hassanshahi","year":"2010","unstructured":"Hassanshahi G, et al. Assessment of CXCL12 (SDF-1\u03b1) polymorphisms and its serum level in posttransfusion occult HBV-infected patients in Southeastern Iran. Arch Med Res. 2010;41(5):338\u201342.","journal-title":"Arch Med Res"},{"key":"3584_CR12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s10147-017-1187-x","volume":"22","author":"A Nazari","year":"2017","unstructured":"Nazari A, Khorramdelazad H, Hassanshahi G. Biological\/pathological functions of the CXCL12\/CXCR4\/CXCR7 axes in the pathogenesis of bladder cancer. Int J Clin Oncol. 2017;22:991\u20131000.","journal-title":"Int J Clin Oncol"},{"key":"3584_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-023-08479-1","author":"M Bocchi","year":"2023","unstructured":"Bocchi M, et al. Involvement of CXCL12\/CXCR4 axis in colorectal cancer: a mini-review. Mol Biol Reports. 2023. https:\/\/doi.org\/10.1007\/s11033-023-08479-1.","journal-title":"Mol Biol Reports"},{"issue":"11","key":"3584_CR14","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.7150\/ijbs.82317","volume":"19","author":"Y Yang","year":"2023","unstructured":"Yang Y, et al. CXCL12-CXCR4\/CXCR7 axis in cancer: from mechanisms to clinical applications. Int J Biol Sci. 2023;19(11):3341.","journal-title":"Int J Biol Sci"},{"issue":"46","key":"3584_CR15","doi-asserted-by":"publisher","first-page":"28960","DOI":"10.1073\/pnas.2013644117","volume":"117","author":"D Biasci","year":"2020","unstructured":"Biasci D, et al. CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proc Natl Acad Sci. 2020;117(46):28960\u201370.","journal-title":"Proc Natl Acad Sci"},{"key":"3584_CR16","volume-title":"Modulation of the tumor microenvironment by the CXCR4 antagonist AMD3100 in pancreatic and colorectal adenocarcinoma","author":"M Smoragiewicz","year":"2019","unstructured":"Smoragiewicz M. Modulation of the tumor microenvironment by the CXCR4 antagonist AMD3100 in pancreatic and colorectal adenocarcinoma. Cambridge: University of Cambridge; 2019."},{"key":"3584_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2023.2256406","author":"H Khorramdelazad","year":"2023","unstructured":"Khorramdelazad H, et al. Antitumor activities of a novel fluorinated small molecule (A1) in CT26 colorectal cancer cells molecular docking and in vitro studies. J Biomol Struct Dyn. 2023. https:\/\/doi.org\/10.1080\/07391102.2023.2256406.","journal-title":"J Biomol Struct Dyn"},{"issue":"1\u20133","key":"3584_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0010-4655(95)00042-E","volume":"91","author":"HJ Berendsen","year":"1995","unstructured":"Berendsen HJ, van der Spoel D, van Drunen R. GROMACS: A message-passing parallel molecular dynamics implementation. Comput Phys Commun. 1995;91(1\u20133):43\u201356.","journal-title":"Comput Phys Commun"},{"issue":"11","key":"3584_CR19","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1529\/biophysj.106.097782","volume":"92","author":"A P\u00e9rez","year":"2007","unstructured":"P\u00e9rez A, et al. Refinement of the AMBER force field for nucleic acids: improving the description of \u03b1\/\u03b3 conformers. Biophys J. 2007;92(11):3817\u201329.","journal-title":"Biophys J"},{"key":"3584_CR20","doi-asserted-by":"publisher","DOI":"10.1063\/1.2408420","author":"G Bussi","year":"2007","unstructured":"Bussi G, Donadio D, Parrinello M. Canonical sampling through velocity rescaling. J Chem Phys. 2007. https:\/\/doi.org\/10.1063\/1.2408420.","journal-title":"J Chem Phys"},{"issue":"12","key":"3584_CR21","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1063\/1.328693","volume":"52","author":"M Parrinello","year":"1981","unstructured":"Parrinello M, Rahman A. Polymorphic transitions in single crystals: A new molecular dynamics method. J Appl Phys. 1981;52(12):7182\u201390.","journal-title":"J Appl Phys"},{"issue":"12","key":"3584_CR22","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden T, York D, Pedersen L. Particle mesh Ewald: An N\u22c5 log (N) method for Ewald sums in large systems. J Chem Phys. 1993;98(12):10089\u201392.","journal-title":"J Chem Phys"},{"issue":"12","key":"3584_CR23","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess B, et al. LINCS: A linear constraint solver for molecular simulations. J Comput Chem. 1997;18(12):1463\u201372.","journal-title":"J Comput Chem"},{"issue":"7","key":"3584_CR24","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1021\/ci500020m","volume":"54","author":"R Kumari","year":"2014","unstructured":"Kumari R, et al. g_mmpbsa A GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model. 2014;54(7):1951\u201362.","journal-title":"J Chem Inf Model"},{"key":"3584_CR25","first-page":"4","volume":"1","author":"DS Biovia","year":"2015","unstructured":"Biovia DS, Dsme R. San Diego: Dassault Syst\u00e8mes. Release. 2015;1:4.","journal-title":"Release"},{"issue":"1","key":"3584_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph. 1996;14(1):33\u20138.","journal-title":"J Mol Graph"},{"key":"3584_CR27","unstructured":"W.L., D.L. An informal Newsletter associated with the BBSRC Collaborative Computational Project No. 4 on Protein Crystallography CCP4 newsletter, On Protein Crystallography. . 2002; https:\/\/legacy.ccp4.ac.uk\/newsletters\/newsletter41.pdf."},{"key":"3584_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-021-10189-4","author":"E Kazemi","year":"2021","unstructured":"Kazemi E, Darehkordi A, Abbasi A. Friedel-Crafts synthesis of bis (trifluoromethylated)-4-aryl-3, 4-dihydroquinazolines, bis (trifluoromethylated)-3, 4-dihydroquinazoline-4-ols and trifluoromethyl arylketoimines using N-aryltrifluoroacetimidoyl chlorides and benzene derivatives. Mol Divers. 2021. https:\/\/doi.org\/10.1007\/s11030-021-10189-4.","journal-title":"Mol Divers"},{"issue":"4","key":"3584_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034038","volume":"7","author":"Z Liang","year":"2012","unstructured":"Liang Z, et al. Development of a unique small molecule modulator of CXCR4. PLoS ONE. 2012;7(4): e34038.","journal-title":"PLoS ONE"},{"issue":"8","key":"3584_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255606","volume":"16","author":"S Smith-Berdan","year":"2021","unstructured":"Smith-Berdan S, et al. Acute and endothelial-specific Robo4 deletion affect hematopoietic stem cell trafficking independent of VCAM1. PLoS ONE. 2021;16(8): e0255606.","journal-title":"PLoS ONE"},{"issue":"19","key":"3584_CR31","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1002\/1878-0261.13218","volume":"16","author":"S Wu","year":"2022","unstructured":"Wu S, et al. miR-126 downregulates CXCL12 expression in intestinal epithelial cells to suppress the recruitment and function of macrophages and tumorigenesis in a murine model of colitis-associated colorectal cancer. Mol Oncol. 2022;16(19):3465\u201389.","journal-title":"Mol Oncol"},{"key":"3584_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-018-1014-x","volume":"38","author":"X Yu","year":"2019","unstructured":"Yu X, et al. CXCL12\/CXCR4 promotes inflammation-driven colorectal cancer progression through activation of RhoA signaling by sponging miR-133a-3p. J Exp Clin Cancer Res. 2019;38:1\u201318.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"3584_CR33","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/10520295.2018.1556806","volume":"94","author":"E Kouvaras","year":"2019","unstructured":"Kouvaras E, et al. Hypoxia-inducible factor 1-alpha and vascular endothelial growth factor in cartilage tumors. Biotech Histochem. 2019;94(4):283\u20139.","journal-title":"Biotech Histochem"},{"key":"3584_CR34","unstructured":"Institutional Animal Care and Use Committee. https:\/\/iacuc.wsu.edu\/guidelines\/. Accessed 12 Dec 2023"},{"issue":"9","key":"3584_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0274886","volume":"17","author":"A Rodallec","year":"2022","unstructured":"Rodallec A, et al. Tumor growth monitoring in breast cancer xenografts: A good technique for a strong ethic. PLoS ONE. 2022;17(9): e0274886.","journal-title":"PLoS ONE"},{"key":"3584_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2016.05.025","volume":"85","author":"V Bagheri","year":"2016","unstructured":"Bagheri V, et al. CXC chemokine CXCL12 tissue expression and circulating levels in peptic ulcer patients with Helicobacter pylori infection. Cytokine. 2016;85:1\u20134.","journal-title":"Cytokine"},{"key":"3584_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijcard.2017.02.011","volume":"233","author":"VT Ferdousie","year":"2017","unstructured":"Ferdousie VT, et al. Serum CXCL10 and CXCL12 chemokine levels are associated with the severity of coronary artery disease and coronary artery occlusion. Int J Cardiol. 2017;233:23\u20138.","journal-title":"Int J Cardiol"},{"key":"3584_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.canlet.2020.01.005","volume":"474","author":"D Wang","year":"2020","unstructured":"Wang D, et al. Exosome-encapsulated miRNAs contribute to CXCL12\/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages. Cancer Lett. 2020;474:36\u201352.","journal-title":"Cancer Lett"},{"issue":"7","key":"3584_CR39","doi-asserted-by":"publisher","first-page":"11746","DOI":"10.1002\/jcp.27831","volume":"234","author":"WB Zhu","year":"2019","unstructured":"Zhu WB, Zhao ZF, Zhou X. AMD3100 inhibits epithelial\u2013mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1\u03b1\/CXCR4 signaling pathway in prostate cancer. J Cell Physiol. 2019;234(7):11746\u201359.","journal-title":"J Cell Physiol"},{"issue":"2","key":"3584_CR40","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/path.3029","volume":"226","author":"FR Balkwill","year":"2012","unstructured":"Balkwill FR. The chemokine system and cancer. J Pathol. 2012;226(2):148\u201357.","journal-title":"J Pathol"},{"key":"3584_CR41","first-page":"3833","volume":"62","author":"Z Is","year":"2003","unstructured":"Is Z. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastasis. Cancer Res. 2003;62:3833\u20139.","journal-title":"Cancer Res"},{"key":"3584_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2045-3329-2-24","volume":"2","author":"D Berghuis","year":"2012","unstructured":"Berghuis D, et al. The CXCR4-CXCL12 axis in Ewing sarcoma: promotion of tumor growth rather than metastatic disease. Clin Sarcoma Res. 2012;2:1\u20139.","journal-title":"Clin Sarcoma Res"},{"issue":"1","key":"3584_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3892\/or.2015.3992","volume":"34","author":"Y-X Liao","year":"2015","unstructured":"Liao Y-X, et al. AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1\/2, pathways in in vitro and mouse experiments. Oncol Rep. 2015;34(1):33\u201342.","journal-title":"Oncol Rep"},{"issue":"15","key":"3584_CR44","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.3748\/wjg.14.2308","volume":"14","author":"J-K Li","year":"2008","unstructured":"Li J-K, et al. Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro. World J Gastroenterol. 2008;14(15):2308.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"3584_CR45","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1002\/hed.24461","volume":"38","author":"YH Jung","year":"2016","unstructured":"Jung YH, et al. Antitumor effect of CXCR4 antagonist AMD3100 on the tumorigenic cell line of BHP10-3 papillary thyroid cancer cells. Head Neck. 2016;38(10):1479\u201386.","journal-title":"Head Neck"},{"key":"3584_CR46","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s12253-020-00827-x","volume":"26","author":"Z Luo","year":"2020","unstructured":"Luo Z, et al. Novel CXCR4 Inhibitor CPZ1344 Inhibits the Proliferation, Migration and Angiogenesis of Glioblastoma. Pathol Oncol Res. 2020;26:2597\u2013604.","journal-title":"Pathol Oncol Res"},{"issue":"21","key":"3584_CR47","doi-asserted-by":"publisher","first-page":"9891","DOI":"10.1158\/0008-5472.CAN-05-1293","volume":"65","author":"P Kukreja","year":"2005","unstructured":"Kukreja P, et al. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1\u03b1 (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK\/ERK signaling pathway\u2013dependent NF-\u03baB activation. Can Res. 2005;65(21):9891\u20138.","journal-title":"Can Res"},{"key":"3584_CR48","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00112.2003","author":"MB Dwinell","year":"2004","unstructured":"Dwinell MB, et al. SDF-1\/CXCL12 regulates cAMP production and ion transport in intestinal epithelial cells via CXCR4. Am J Physiol-Gastrointest Liver Physiol. 2004. https:\/\/doi.org\/10.1152\/ajpgi.00112.2003.","journal-title":"Am J Physiol-Gastrointest Liver Physiol"},{"key":"3584_CR49","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.omto.2020.06.009","volume":"18","author":"J Zhou","year":"2020","unstructured":"Zhou J, et al. CXCR4 antagonist AMD3100 reverses the resistance to tamoxifen in breast cancer via inhibiting AKT phosphorylation. Mol Ther-Oncolytics. 2020;18:161\u201370.","journal-title":"Mol Ther-Oncolytics"},{"issue":"13","key":"3584_CR50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2015433118","volume":"118","author":"J-S Song","year":"2021","unstructured":"Song J-S, et al. A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment. Proc Natl Acad Sci. 2021;118(13): e2015433118.","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"3584_CR51","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1182\/blood-2004-12-4918","volume":"106","author":"M Burger","year":"2005","unstructured":"Burger M, et al. Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. Blood. 2005;106(5):1824\u201330.","journal-title":"Blood"},{"issue":"22","key":"3584_CR52","doi-asserted-by":"publisher","first-page":"6765","DOI":"10.1158\/1078-0432.CCR-06-1372","volume":"12","author":"N Redjal","year":"2006","unstructured":"Redjal N, et al. CXCR4 inhibition synergizes with cytotoxic chemotherapy in gliomas. Clin Cancer Res. 2006;12(22):6765\u201371.","journal-title":"Clin Cancer Res"},{"issue":"17","key":"3584_CR53","doi-asserted-by":"publisher","first-page":"5670","DOI":"10.1158\/0008-5472.CAN-11-0268","volume":"71","author":"N Halama","year":"2011","unstructured":"Halama N, et al. Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy. Can Res. 2011;71(17):5670\u20137.","journal-title":"Can Res"},{"key":"3584_CR54","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1245\/s10434-012-2668-9","volume":"20","author":"SC Katz","year":"2013","unstructured":"Katz SC, et al. Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases. Ann Surg Oncol. 2013;20:946\u201355.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"3584_CR55","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1158\/2326-6066.CIR-17-0530","volume":"6","author":"B Li","year":"2018","unstructured":"Li B, et al. AMD3100 augments the efficacy of mesothelin-targeted, immune-activating VIC-008 in mesothelioma by modulating intratumoral immunosuppression. Cancer Immunol Res. 2018;6(5):539\u201351.","journal-title":"Cancer Immunol Res"},{"issue":"5","key":"3584_CR56","doi-asserted-by":"publisher","first-page":"6596","DOI":"10.1096\/fj.201802067RR","volume":"33","author":"Y Zeng","year":"2019","unstructured":"Zeng Y, et al. Dual blockade of CXCL12-CXCR4 and PD-1\u2013PD-L1 pathways prolongs survival of ovarian tumor\u2013bearing mice by prevention of immunosuppression in the tumor microenvironment. FASEB J. 2019;33(5):6596.","journal-title":"FASEB J"},{"issue":"2","key":"3584_CR57","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ajodo.2021.03.018","volume":"162","author":"N Ongprakobkul","year":"2022","unstructured":"Ongprakobkul N, et al. Effects of local vs systemic administration of CXCR4 inhibitor AMD3100 on orthodontic tooth movement in rats. Am J Orthod Dentofac Orthop. 2022;162(2):182\u201392.","journal-title":"Am J Orthod Dentofac Orthop"},{"issue":"9","key":"3584_CR58","first-page":"1843","volume":"120","author":"T Itkin","year":"2012","unstructured":"Itkin T, et al. FGF-2 expands murine hematopoietic stem and progenitor cells via proliferation of stromal cells, c-Kit activation, and CXCL12 down-regulation. Blood, J Am Soc Hematol. 2012;120(9):1843\u201355.","journal-title":"Blood, J Am Soc Hematol"},{"issue":"7","key":"3584_CR59","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1158\/1535-7163.MCT-12-1092","volume":"12","author":"X Sun","year":"2013","unstructured":"Sun X, et al. CXCR4-targeted therapy inhibits VEGF expression and chondrosarcoma angiogenesis and metastasis. Mol Cancer Ther. 2013;12(7):1163\u201370.","journal-title":"Mol Cancer Ther"},{"issue":"39","key":"3584_CR60","doi-asserted-by":"publisher","first-page":"10455","DOI":"10.1073\/pnas.1710754114","volume":"114","author":"K Jung","year":"2017","unstructured":"Jung K, et al. Targeting CXCR4-dependent immunosuppressive Ly6Clow monocytes improves antiangiogenic therapy in colorectal cancer. Proc Natl Acad Sci. 2017;114(39):10455\u201360.","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"3584_CR61","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1084\/jem.20080730","volume":"205","author":"M Meiron","year":"2008","unstructured":"Meiron M, et al. CXCL12 (SDF-1\u03b1) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells. J Exp Med. 2008;205(11):2643\u201355.","journal-title":"J Exp Med"},{"key":"3584_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119132","volume":"284","author":"V Karpisheh","year":"2021","unstructured":"Karpisheh V, et al. The role of regulatory T cells in the pathogenesis and treatment of prostate cancer. Life Sci. 2021;284: 119132.","journal-title":"Life Sci"},{"issue":"8","key":"3584_CR63","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1593\/neo.12324","volume":"14","author":"UM Domanska","year":"2012","unstructured":"Domanska UM, et al. CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy. Neoplasia. 2012;14(8):709\u201318.","journal-title":"Neoplasia"},{"key":"3584_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-016-0587-6","volume":"13","author":"I Rabinovich-Nikitin","year":"2016","unstructured":"Rabinovich-Nikitin I, et al. Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1 G93A mice model of ALS. J Neuroinflammation. 2016;13:1\u201311.","journal-title":"J Neuroinflammation"},{"issue":"21","key":"3584_CR65","doi-asserted-by":"publisher","first-page":"E2182","DOI":"10.1073\/pnas.1404943111","volume":"111","author":"T Yi","year":"2014","unstructured":"Yi T, et al. Quantitative phosphoproteomic analysis reveals system-wide signaling pathways downstream of SDF-1\/CXCR4 in breast cancer stem cells. Proc Natl Acad Sci. 2014;111(21):E2182\u201390.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"3584_CR66","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1158\/1541-7786.MCR-10-0235","volume":"9","author":"MA Chetram","year":"2011","unstructured":"Chetram MA, Odero-Marah V, Hinton CV. Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1\/2 in prostate cancer cells. Mol Cancer Res. 2011;9(1):90\u2013102.","journal-title":"Mol Cancer Res"},{"issue":"4","key":"3584_CR67","first-page":"2022","volume":"39","author":"A Benedicto","year":"2018","unstructured":"Benedicto A, Romayor I, Arteta B. CXCR4 receptor blockage reduces the contribution of tumor and stromal cells to the metastatic growth in the liver. Oncol Rep. 2018;39(4):2022\u201330.","journal-title":"Oncol Rep"},{"key":"3584_CR68","doi-asserted-by":"publisher","DOI":"10.2393\/2378-3419\/1410144","author":"Z Liu","year":"2021","unstructured":"Liu Z, Wang J, Chen H. CXCR4 antagonist AMD3100 (Plerixafor) modulates immune responses in the tumor microenvironment. Int J Cancer Clin Res. 2021. https:\/\/doi.org\/10.2393\/2378-3419\/1410144.","journal-title":"Int J Cancer Clin Res"},{"key":"3584_CR69","doi-asserted-by":"publisher","DOI":"10.1039\/D3DT01729J","author":"SO Alzahrani","year":"2024","unstructured":"Alzahrani SO, et al. Trans-IV restriction a new configuration for metal bis-cyclam complexes as potent CXCR4 inhibitors. Dalton Transact. 2024. https:\/\/doi.org\/10.1039\/D3DT01729J.","journal-title":"Dalton Transact"},{"issue":"7","key":"3584_CR70","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/hepr.12411","volume":"45","author":"Y Saiman","year":"2015","unstructured":"Saiman Y, et al. Inhibition of the CXCL 12\/CXCR 4 chemokine axis with AMD 3100, a CXCR 4 small molecule inhibitor, worsens murine hepatic injury. Hepatol Res. 2015;45(7):794\u2013803.","journal-title":"Hepatol Res"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-024-03584-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-024-03584-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-024-03584-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T18:01:59Z","timestamp":1736100119000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-024-03584-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,5]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3584"],"URL":"https:\/\/doi.org\/10.1186\/s12935-024-03584-y","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,5]]},"assertion":[{"value":"8 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"BALB\/C mice were used in this study following ethical guidelines, and no human samples were involved. The Iran University of Medical Sciences Ethics Committee approved the experimental procedures under the approval code IR.IUMS.FMD.REC.1400.590.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}